SCHEMBL23725210

SCHEMBL23725210

CN1CCN(C(=O)O)Cc2cc(Br)ccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 1/20 0.44
BRD4 O60885 1/20 0.40
RBP4 P02753 1/20 0.40
HRH4 Q9H3N8 2/20 0.39
HRH3 Q9Y5N1 1/20 0.39
DPP8 Q6V1X1 1/20 0.39
DPP9 Q86TI2 1/20 0.39
DPP7 Q9UHL4 1/20 0.39
POLB P06746 1/20 0.38
HSD17B3 P37058 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ABHD6 Q9BV23 3/20 0.37
ALDH1A1 P00352 3/20 0.37
DUSP3 P51452 2/20 0.37
PTPN5 P54829 2/20 0.37
PTPN11 Q06124 2/20 0.37
MYC P01106 1/20 0.37
NR4A1 P22736 1/20 0.37
CASP2 P42575 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23725803 0.81 ESR2 (0.49) CREBBPRBP4ABHD6ALDH1A1LMNA
SCHEMBL587507 0.75 ABHD6 (0.59) DPP8DPP9DPP7HSD17B3NPC1
SCHEMBL3808915 0.75 ABHD6 (0.59) DPP8DPP9DPP7HSD17B3NPC1
SCHEMBL31598007 0.75 ABHD6 (0.59) DPP8DPP9DPP7HSD17B3NPC1
SCHEMBL10171016 0.75 BRD4 (0.53) BRD4HSD17B3CASP2LMNA
SCHEMBL1956852 0.74 ABHD6 (0.55) DPP8DPP9DPP7HSD17B3NPC1
SCHEMBL4437450 0.74 ABHD6 (0.55) DPP8DPP9DPP7HSD17B3NPC1
SCHEMBL18228228 0.74 CASP2 (0.45) RBP4HSD17B3MYCNR4A1CASP2
SCHEMBL25169144 0.73 P2RX7 (0.46) HRH4HRH3POLBHSD17B3ALDH1A1
SCHEMBL1263462 0.73 ABHD6 (0.50) DPP8DPP9DPP7HSD17B3ABHD6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 US disclosed
EP-4100381-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2022-12-14 EP disclosed
WO-2021158481-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME HAVCR2, HMBS, VHL CREBBP 3566/4885BRD4 35/4885RBP4 921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.